tm
Seeing Is Believing
tm
Seeing Is Believing
CANF is currently covered by 1 analysts with an average price target of $-7.98. This is a potential upside of $-12.54 (-275%) from yesterday's end of day stock price of $4.56.
Can Fite Biopharma Ltd ADR's activity chart (see below) currently has 13 price targets and 21 ratings on display. The stock rating distribution of CANF is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 96.43% with an average time for these price targets to be met of 279 days.
Highest price target for CANF is $4, Lowest price target is $4, average price target is $4.
Most recent stock forecast was given by JASON KOLBERT from BENCHMARK on 17-Dec-2025. First documented stock forecast 24-Sep-2019.
Currently out of the existing stock ratings of CANF, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Aug-2024
$4
$-0.65 (-13.98%)
$11
2 months 7 days ago
(17-Dec-2025)
13/14 (92.86%)
$-1.47 (-26.87%)
213
Buy Since 24-Sep-2019
$18
$13.35 (287.10%)
$18
1 years 3 months 12 days ago
(12-Nov-2024)
6/6 (100%)
$-23.6 (-56.73%)
345
What is CANF (Can Fite Biopharma Ltd ADR) average time for price targets to be met?
Which analyst has the current highest performing score on CANF (Can Fite Biopharma Ltd ADR) with a proven track record?
Which analyst has the current lower performing score on CANF (Can Fite Biopharma Ltd ADR) with a proven track record?
Which analyst has the most public recommendations on CANF (Can Fite Biopharma Ltd ADR)?
Which analyst is the currently most bullish on CANF (Can Fite Biopharma Ltd ADR)?
Which analyst is the currently most reserved on CANF (Can Fite Biopharma Ltd ADR)?
